Dr Chang Liu


Chang has more than 10 years’ research and consultancy experience and has worked across a range of different projects, including PRMA Healthcheck® gap analyses to develop evidence generation roadmaps to support market access and P&R submissions, value proposition development and testing, advisory boards, treatment patterns surveys, market research on the role of real-world evidence and initiatives in market access, and HTA and P&R landscape assessments.

Chang also has significant knowledge around P&R systems in Asia-Pacific countries and has been involved in many projects to develop market access and evidence generation strategies to support successful product launch in these markets, across a range of disease areas and products.

Chang’s research experience was in neuroscience and she holds a PhD from King’s College London.